Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery
- PMID: 20152959
- DOI: 10.1016/j.ajo.2009.12.010
Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery
Abstract
Purpose: To compare the anti-inflammatory efficacy and subjective tolerability of preservative-free and preserved diclofenac 0.1% and preserved ketorolac 0.5% eye drops for prophylaxis and management of inflammation after cataract surgery.
Design: Prospective, randomized, investigator-masked, parallel-group, comparative clinical trial.
Methods: One hundred two patients who underwent small-incision phacoemulsification cataract surgery in an institutional setting were assigned randomly to receive preservative-free diclofenac sodium 0.1% (Voltaren ophtha SDU; Novartis Pharma), preserved diclofenac sodium 0.1% (Voltaren ophtha; Novartis Pharma), or preserved ketorolac tromethamine 0.5% (Acular; Pharm Allergan) eyedrops 4 times daily for 4 weeks after surgery. During the 1-month follow-up, anterior chamber flare and mean foveal thickness were evaluated for objective comparison of the anti-inflammatory effect. Ocular tolerability was assessed by observer-based grading of conjunctival hyperemia and ocular discomfort, as well as obtaining subjective ratings of ocular tolerability on a visual analog scale. Distance and near visual acuity and intraocular pressure served as safety measures.
Results: All 3 formulations demonstrated equal anti-inflammatory efficacy as measured by reduction of anterior chamber flare after surgery and prevention of postoperative macular edema. Patients treated with preservative-free diclofenac eyedrops reported significantly better subjective tolerability values (P = .001), were classified as having less ocular discomfort (P < .001), and experienced earlier reduction of postoperative conjunctival hyperemia (P = .029).
Conclusions: Anti-inflammatory efficacy was comparable for all 3 agents. However, preservative-free diclofenac 0.1% eyedrops exhibited a significantly better postoperative subjective and objective tolerability when compared with preserved eyedrops containing ketorolac or diclofenac.
Copyright 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Ketorolac 0.45% ophthalmic solution.Drugs Aging. 2011 Jul 1;28(7):583-9. doi: 10.2165/11207450-000000000-00000. Drugs Aging. 2011. PMID: 21721602 Review.
-
Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.Ophthalmology. 1998 Sep;105(9):1775-9. doi: 10.1016/S0161-6420(98)99053-4. Ophthalmology. 1998. PMID: 9754191 Clinical Trial.
-
Incidence of postoperative posterior capsular opacification following treatment with diclofenac 0.1% and ketorolac 0.5% ophthalmic solutions: 3-year randomized, double-masked, prospective clinical investigation.Trans Am Ophthalmol Soc. 2000;98:101-5; discussion 105-7. Trans Am Ophthalmol Soc. 2000. PMID: 11190013 Free PMC article. Clinical Trial.
-
Comparison of the efficacy and safety of two formulations of diclofenac sodium 0.1% eyedrops in controlling postoperative inflammation after cataract surgery.Eur J Ophthalmol. 2005 Nov-Dec;15(6):702-11. doi: 10.1177/112067210501500608. Eur J Ophthalmol. 2005. PMID: 16329054 Clinical Trial.
-
[Preservatives in eye drops: toward awareness of their toxicity].J Fr Ophtalmol. 2010 Sep;33(7):505-24. doi: 10.1016/j.jfo.2010.06.018. Epub 2010 Sep 15. J Fr Ophtalmol. 2010. PMID: 20832141 Review. French.
Cited by
-
A meta-analysis of topical Ketorolac's effect on surgical site wound healing post-cataract surgery.Int Wound J. 2024 Jan;21(1):e14661. doi: 10.1111/iwj.14661. Int Wound J. 2024. Retraction in: Int Wound J. 2025 Apr;22(4):e70578. doi: 10.1111/iwj.70578. PMID: 38272819 Free PMC article. Retracted.
-
Ketorolac 0.45% ophthalmic solution.Drugs Aging. 2011 Jul 1;28(7):583-9. doi: 10.2165/11207450-000000000-00000. Drugs Aging. 2011. PMID: 21721602 Review.
-
Critical appraisal of ophthalmic ketorolac in treatment of pain and inflammation following cataract surgery.Clin Ophthalmol. 2011;5:751-8. doi: 10.2147/OPTH.S7633. Epub 2011 Jun 3. Clin Ophthalmol. 2011. PMID: 21750608 Free PMC article.
-
Measuring Anterior Chamber Inflammation After Cataract Surgery: A Review of the Literature Focusing on the Correlation with Cystoid Macular Edema.Clin Ophthalmol. 2020 Jan 9;14:41-52. doi: 10.2147/OPTH.S237405. eCollection 2020. Clin Ophthalmol. 2020. PMID: 32021067 Free PMC article. Review.
-
Laser flare and cell photometry to measure inflammation after cataract surgery: a tool to predict the risk of cystoid macular edema.Int Ophthalmol. 2021 Jun;41(6):2293-2300. doi: 10.1007/s10792-021-01779-0. Epub 2021 Mar 21. Int Ophthalmol. 2021. PMID: 33745035 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical